Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Silver R, Craigo S, Porter F, Osmundson SS, Kuller JA, Norton ME.
Am J Obstet Gynecol. 2023 Mar;228(3):B41-B60. doi: 10.1016/j.ajog.2022.09.001. Epub 2022 Sep 6.
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A.
Curr Probl Cardiol. 2017 Jul;42(7):198-225. doi: 10.1016/j.cpcardiol.2017.03.001. Epub 2017 Mar 8.
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.
Gaitskell K, Rogozińska E, Platt S, Chen Y, Abd El Aziz M, Tattersall A, Morrison J.
Cochrane Database Syst Rev. 2023 Apr 18;4(4):CD007930. doi: 10.1002/14651858.CD007930.pub3.
Obesity, Visceral Fat, and Hypertension-Related Complications.
Haberka M, Stolarz-Skrzypek K, Biedroń M, Szóstak-Janiak K, Partyka M, Olszanecka-Glinianowicz M, Gąsior Z.
Metab Syndr Relat Disord. 2018 Dec;16(10):521-529. doi: 10.1089/met.2018.0062. Epub 2018 Sep 5.
Hypertension, dyslipidaemia, and cardiovascular risk in HIV-infected adults in Poland.
Rogalska-Płońska M, Rogalski P, Leszczyszyn-Pynka M, Stempkowska J, Kocbach P, Kowalczuk-Kot A, Janczarek M, Grzeszczuk A.
Kardiol Pol. 2017;75(12):1324-1331. doi: 10.5603/KP.a2017.0148. Epub 2017 Jul 17.
Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.
Thomopoulos C, Parati G, Zanchetti A.
J Hypertens. 2014 Dec;32(12):2296-304. doi: 10.1097/HJH.0000000000000379.
Age-specific differences in hypertension combination management and associated factors influencing treatment choice.
Xiong J, Wang L, Yang C, Huang H, He B, Shen L, Su F.
J Clin Hypertens (Greenwich). 2023 Jun;25(6):545-554. doi: 10.1111/jch.14668. Epub 2023 May 17.
Correlation Analysis of NAMPT rs61330082 Polymorphism in Type 2 Diabetes Mellitus Combined with Hypertension.
Zuo C, Liu Y, Wang Z, Cheng J, Yang D, Gong H, Wang Y, Qiao Y.
Diabetes Metab Syndr Obes. 2024 Apr 18;17:1809-1818. doi: 10.2147/DMSO.S458416. eCollection 2024.
Cardiometabolic Risk in a University Community: An Observational Study.
Pérez-Manchón D, Barrio-Cortes J, Vicario-Merino A, Mayoral-Gonzalo N, Ruiz-López M, Corral-Pugnaire E, Blanco-Hermo P, Ruiz-Zaldibar C.
Healthcare (Basel). 2024 Sep 3;12(17):1756. doi: 10.3390/healthcare12171756.
Retrospective, Observational Study to Determine the Choice of Antihypertensive agent According to Stage of Hypertension, Risk factors and Co-morbidities in Real World Setting in India: A Report of Baseline Data.
Khan MY, Pandit S, Dalal J, Bansal S, Iyengar SS, Karnik R, Khanna U, Mane A, Mehta S, Shah S.
J Assoc Physicians India. 2021 Jun;69(6):11-12.
